Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NF-kappaB in carcinoma therapy and prevention.
Brown M, Cohen J, Arun P, Chen Z, Van Waes C. Brown M, et al. Among authors: arun p. Expert Opin Ther Targets. 2008 Sep;12(9):1109-22. doi: 10.1517/14728222.12.9.1109. Expert Opin Ther Targets. 2008. PMID: 18694378 Free PMC article. Review.
CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
Brown MS, Diallo OT, Hu M, Ehsanian R, Yang X, Arun P, Lu H, Korman V, Unger G, Ahmed K, Van Waes C, Chen Z. Brown MS, et al. Among authors: arun p. Clin Cancer Res. 2010 Apr 15;16(8):2295-307. doi: 10.1158/1078-0432.CCR-09-3200. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371694 Free PMC article.
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.
Gilbert J, Lee JW, Argiris A, Haigentz M Jr, Feldman LE, Jang M, Arun P, Van Waes C, Forastiere AA. Gilbert J, et al. Among authors: arun p. Head Neck. 2013 Jul;35(7):942-8. doi: 10.1002/hed.23046. Epub 2012 Jul 13. Head Neck. 2013. PMID: 22791234 Free PMC article. Clinical Trial.
HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.
Friedman JA, Wise SC, Hu M, Gouveia C, Vander Broek R, Freudlsperger C, Kannabiran VR, Arun P, Mitchell JB, Chen Z, Van Waes C. Friedman JA, et al. Among authors: arun p. Transl Oncol. 2013 Aug 1;6(4):429-41. doi: 10.1593/tlo.13292. Print 2013 Aug. Transl Oncol. 2013. PMID: 23908686 Free PMC article.
210 results